Advertisement
Screener

PLx Pharma Winddown Corp. Financing Cash Flow

PLx Pharma Winddown Corp. Financing Cash Flow

PLx Pharma Winddown Corp. reported Financing Cash Flow of $2.42 million for the 9-month period ending 2022-09-30, per its 10-Q filed 2022-11-10.

Discontinued › Cash Flow › Financing Activities

us-gaap:NetCashProvidedByUsedInFinancingActivities · last filed 2022-11-10

  • PLx Pharma Winddown Corp. net cash provided by (used in) financing activities for the quarter ending 2022-09-30 was $1.09M, a 90.42% decline year-over-year.
  • PLx Pharma Winddown Corp. net cash provided by (used in) financing activities for the quarter ending 2022-06-30 was $1.33M, a 12.90% increase year-over-year.
  • PLx Pharma Winddown Corp. net cash provided by (used in) financing activities for the quarter ending 2022-03-31 was $0.00, a 100.00% decline year-over-year.
  • PLx Pharma Winddown Corp. net cash provided by (used in) financing activities for the quarter ending 2021-12-31 was $198.00K, a 98.75% decline year-over-year.
  • PLx Pharma Winddown Corp. net cash provided by (used in) financing activities for fiscal 2021 was $78.97M, a 279.77% increase from fiscal 2020.
  • PLx Pharma Winddown Corp. net cash provided by (used in) financing activities for fiscal 2020 was $20.79M, a 64.50% increase from fiscal 2019.
  • PLx Pharma Winddown Corp. net cash provided by (used in) financing activities for fiscal 2019 was $12.64M.
  • PLx Pharma Winddown Corp. net cash provided by (used in) financing activities for fiscal 2017 was $26.41M, a 1385.78% increase from fiscal 2016.
Period endNet Cash Provided by (Used in) Financing Activities 3 monthNet Cash Provided by (Used in) Financing Activities 3 month as first filedNet Cash Provided by (Used in) Financing Activities 6 monthNet Cash Provided by (Used in) Financing Activities 6 month as first filedNet Cash Provided by (Used in) Financing Activities 9 monthNet Cash Provided by (Used in) Financing Activities 9 month as first filedNet Cash Provided by (Used in) Financing Activities 12 monthNet Cash Provided by (Used in) Financing Activities 12 month as first filed
2022-09-30$1.09M
derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-10
$2.42M
derived: sum of 2 quarters · filed 2022-11-10
$2.42M
10-Q · filed 2022-11-10
$2.61M
derived: sum of 4 quarters · filed 2022-11-10
2022-06-30$1.33M
derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-12
$1.33M
10-Q · filed 2022-08-12
$1.53M
derived: sum of 3 quarters · filed 2022-08-12
$12.86M
derived: sum of 4 quarters · filed 2022-11-10
2022-03-31$0.00
10-Q · filed 2022-05-13
$198.00K
derived: sum of 2 quarters · filed 2022-05-13
$11.53M
derived: sum of 3 quarters · filed 2022-11-10
$12.71M
derived: sum of 4 quarters · filed 2022-11-10
2021-12-31$198.00K
derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-11
$11.53M
derived: sum of 2 quarters · filed 2022-11-10
$12.71M
derived: sum of 3 quarters · filed 2022-11-10
$78.97M
10-K · filed 2022-03-11
2021-09-30$11.33M
derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-10
$12.51M
derived: sum of 2 quarters · filed 2022-11-10
$78.77M
10-Q · filed 2022-11-10
$78.77M
10-Q · filed 2021-11-12
$94.65M
derived: sum of 4 quarters · filed 2022-11-10
2021-06-30$1.18M
derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-12
$67.44M
10-Q · filed 2022-08-12
$67.43M
10-Q · filed 2021-08-06
$83.32M
derived: sum of 3 quarters · filed 2022-08-12
$82.37M
derived: sum of 4 quarters · filed 2022-08-12
2021-03-31$66.26M
10-Q · filed 2022-05-13
$66.26M
10-Q · filed 2021-05-14
$82.14M
derived: sum of 2 quarters · filed 2022-05-13
$81.19M
derived: sum of 3 quarters · filed 2022-05-13
$87.99M
derived: sum of 4 quarters · filed 2022-05-13
2020-12-31$15.88M
derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-11
$14.94M
derived: sum of 2 quarters · filed 2022-03-11
$21.73M
derived: sum of 3 quarters · filed 2022-03-11
$20.79M
10-K · filed 2022-03-11
$20.79M
10-K · filed 2021-03-12
2020-09-30-$945.57K
derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-12
$5.85M
derived: sum of 2 quarters · filed 2021-11-12
$4.91M
10-Q · filed 2021-11-12
$4.14M
derived: sum of 4 quarters · filed 2021-11-12
2020-06-30$6.79M
derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-06
$5.86M
10-Q · filed 2021-08-06
$5.08M
derived: sum of 3 quarters · filed 2021-08-06
$5.62M
derived: sum of 4 quarters · filed 2021-08-06
2020-03-31-$937.50K
10-Q · filed 2021-05-14
-$1.71M
derived: sum of 2 quarters · filed 2021-05-14
-$1.17M
derived: sum of 3 quarters · filed 2021-05-14
-$1.65M
derived: sum of 4 quarters · filed 2021-05-14
2019-12-31-$775.70K
derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-12
-$234.11K
derived: sum of 2 quarters · filed 2021-03-12
-$708.71K
derived: sum of 3 quarters · filed 2021-03-12
$12.64M
10-K · filed 2021-03-12
2019-09-30$541.59K
derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-13
$66.99K
derived: sum of 2 quarters · filed 2020-11-13
$13.42M
10-Q · filed 2020-11-13
2019-06-30-$474.60K
derived: 10-Q 6 month − 10-Q 3 month · filed 2020-08-14
$12.87M
10-Q · filed 2020-08-14
2019-03-31$13.35M
10-Q · filed 2020-05-15
2017-12-31$0.00
derived: 10-K 12 month − 10-Q 9 month · filed 2019-03-08
$7.15M
derived: sum of 2 quarters · filed 2019-03-08
$23.84M
derived: sum of 3 quarters · filed 2019-03-08
$26.41M
10-K · filed 2019-03-08
2017-09-30$7.15M
derived: 10-Q 9 month − 10-Q 6 month · filed 2018-11-09
$23.84M
derived: sum of 2 quarters · filed 2018-11-09
$26.41M
10-Q · filed 2018-11-09
$26.69M
derived: sum of 4 quarters · filed 2018-11-09
2017-06-30$16.70M
derived: 10-Q 6 month − 10-Q 3 month · filed 2018-08-10
$19.27M
10-Q · filed 2018-08-10
$19.54M
derived: sum of 3 quarters · filed 2018-08-10
2017-03-31$2.57M
10-Q · filed 2018-05-11
$2.84M
derived: sum of 2 quarters · filed 2018-05-11
2016-12-31$275.00K
derived: 10-K 12 month − 10-Q 9 month · filed 2018-03-23
$1.78M
10-K · filed 2018-03-23
2016-09-30$1.50M
10-Q · filed 2017-11-09